open access
[131I]I-MIBG-negative metastases of a recurrent sporadic paraganglioma in a female with achondroplasia
Affiliations- Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland
- Department of Nuclear Medicine, Military Institute of Medicine, Warsaw, Poland
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
recurrent; malignant paraganglioma; MIBG-scintigraphy; [18F]F-DOPA PET
About this articleTitle
[131I]I-MIBG-negative metastases of a recurrent sporadic paraganglioma in a female with achondroplasia
Journal
Issue
Article type
Clinical vignette
Pages
113-114
Published online
2023-01-09
Page views
2661
Article views/downloads
332
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2023;74(1):113-114.
Keywords
recurrent
malignant paraganglioma
MIBG-scintigraphy
[18F]F-DOPA PET
Authors
Nadia Sawicka-Gutaj
Maria Majchrzak-Hernandez
Rafał Czepczyński
Alicja Sałyga
Bartłomiej Budny
Ewelina Szczepanek-Parulska
Mirosław Dziuk
Marek Ruchała
References (5)- Kurisaki-Arakawa A, Saito T, Takahashi M, et al. A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literature. Int J Clin Exp Pathol. 2014; 7(7): 4438–4447.
- Mackenzie IS, Gurnell M, Balan KK, et al. The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma. Eur J Endocrinol. 2007; 157(4): 533–537.
- Rzepka E, Gilis-Januszewska A, Opalińska M, et al. Difficulties in the diagnosis and treatment of malignant paraganglioma of the urinary bladder. Endokrynol Pol. 2020; 71(2): 196–197.
- Rufini V, Treglia G, Castaldi P, et al. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Nucl Med Commun. 2011; 32(7): 575–582.
- Fiebrich HB, Brouwers AH, Kerstens MN, et al. 6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess. J Clin Endocrinol Metab. 2009; 94(10): 3922–3930.
